The Challenges of Bringing AI into the Pharma...

A surge in AI adoption is forcing enterprises to expose sensitive data to new systems and access paths, creating security risks that traditional perimeter models can't contain. In this episode, Todd Vancil, Vice President of Veeam's Securiti AI Sales Engineering Team, examines ho ...  Show more

Enterprises rushing agentic AI into production are running it through approval gates, batch windows, and audit systems built for human speed — and the gap is where most operational risk lives. In this episode, Chris Caldwell, President and CEO at Concentrix Corporation, examines ...  Show more

Vijay Pande, founding general partner, and Julie Yoo, general partner at a16z Bio + Health, come together to discuss the grand challenges facing healthcare AI today.

The talk through the implications of AI integration in healthcare workflows, AI as a potential catalyst f ...

What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ...

Rajan Nagina, Head of the AI Practice at Newgen Software, discusses scaling business with AI. How can AI help us scale and grow? What are the opportunities today? And how can we make better use of AI to build a competitive advantage? Listen fo ...

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ...  Show more